Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -1.076\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a Cc1cnc(NC(=O)C2CC(=O)N(c3cccc(Cl)c3)C2)s1
b Cc1[nH]c(=S)[nH]c(=O)c1CCCO
c CC(C)[C@H](NC(=O)[C@@H]1Cc2ccccc2CN1C(=O)OC(C)(C)C)C(=O)NCC1CCC(C(=O)O)CC1
d C[n+]1ccc(/C=C/c2c[nH]c3ccccc23)cc1.[I-]
e CCN(CC)S(=O)(=O)c1ccc2oc(C(=O)O)c(C)c2c1
Answer: a. Cc1cnc(NC(=O)C2CC(=O)N(c3cccc(Cl)c3)C2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cnc(NC(=O)C2CC(=O)N(c3cccc(Cl)c3)C2)s1
Cc1cnc(NC(=O)C2CC(=O)N(c3cccc(Cl)c3)C2)s1
1-(3-chlorophenyl)-N-(5-methyl-1,3-thiazol-2-yl)-5-oxopyrrolidine-3-carboxamide